Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.
Related Posts
Symbiotec Pharmalab IPO opens today: GMP signals 41% upside — Should you subscribe?
Symbiotec Pharmalab’s Rs 1,757 crore IPO opens August 24, with a Rs 938–988 price band and 41% grey-market premium. The issue combines fresh shares and an OFS, while proceeds will partly repay debt. Its specialised API manufacturing, regulatory approvals and biotechnology capabilities offer investors exposure to India’s pharmaceutical manufacturing growth.
super.money eyes commerce push with pay-in-three credit product
SplitStore is a closed-loop, small-ticket credit product designed primarily for new-to-credit users.
The Primary Car Shift: Why Indian Families Are Betting on EVs
The Primary Car Shift: Why Indian Families Are Betting on EVs